GemVax&KAEL Co.,Ltd (082270.KQ)
KRW 13880.0
(-2.94%)
KRW 13880.0
(-2.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 3.56 Billion | -2.95 Billion | -3.46 Billion | 13.95 Billion | -712.1 Million |
| Net Income | -27.17 Billion | -19.6 Billion | 12.05 Billion | 1.63 Billion | -94.78 Billion |
| Depreciation & Amortization | 3.99 Billion | 3.03 Billion | 2.31 Billion | 1.71 Billion | 1.68 Billion |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | 4.24 Billion | 1.61 Billion |
| Change in working capital | 5.06 Billion | -3.36 Billion | -4.76 Billion | 4.75 Billion | 268.16 Million |
| Other non-cash items | 204.47 Million | -799.29 Million | -196.82 Million | -10.56 Billion | 90.51 Billion |
| Investing Cash Flow | -10.51 Billion | 6.49 Billion | -28.06 Billion | -21.32 Billion | 20.28 Billion |
| Investments in PPE | -9.11 Billion | -10.83 Billion | -9.51 Billion | -12.96 Billion | -905.01 Million |
| Acquisitions | -2.31 Billion | - | -18.02 Billion | -10.83 Billion | -4.51 Billion |
| Investment purchases | -503.1 Million | -1.18 Billion | -7.76 Billion | -17.1 Billion | - |
| Sales/Maturities of investments | 1.05 Billion | 15.77 Billion | 3.8 Billion | 12.44 Billion | - |
| Other Investing Activities | 255.08 Million | 2 Billion | 365.83 Million | 1 Billion | 21.18 Billion |
| Financing Cash Flow | 7.73 Billion | -5.97 Billion | -661.11 Million | 3.02 Billion | 78.48 Million |
| Debt repayment | -8.33 Billion | -1 Billion | -661.11 Million | -3.5 Billion | -78.48 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | -6.34 Billion | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | 8.33 Billion | 1 Billion | - | 3.5 Billion | -350.00 |
| Accounts receivables | -993.87 Million | 2.95 Billion | -2.3 Billion | 3.2 Billion | -571.85 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | 3.9 Billion | -3.39 Billion | -2.09 Billion | -869.8 Million | 507.56 Million |
| Other working capital | 1.69 Billion | -1.9 Billion | -1 Billion | 2.52 Billion | 332.45 Million |
| Cash at beginning of period | 15.79 Billion | 18.71 Billion | 50.77 Billion | 55.35 Billion | 35.46 Billion |
| Cash at end of period | 16.51 Billion | 15.79 Billion | 18.71 Billion | 50.77 Billion | 55.35 Billion |
| Capital Expenditure | -9.11 Billion | -10.83 Billion | -9.51 Billion | -12.96 Billion | -905.01 Million |
| Effect of forex changes on cash | -70.18 Million | -476.63 Million | 142.67 Million | -234.28 Million | 241.52 Million |
| Net cash flow / Change in cash | 720.01 Million | -2.91 Billion | -32.05 Billion | -4.58 Billion | 19.88 Billion |
| Free Cash Flow | -5.55 Billion | -13.78 Billion | -12.98 Billion | 990.28 Million | -1.61 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.2 Billion | -34.51 Billion | -12.83 Billion | -27.17 Billion | -7.36 Billion | -907.31 Million |
| Depreciation & Amortization | 1.07 Billion | 1.07 Billion | 1.11 Billion | 3.99 Billion | 1.03 Billion | 975.07 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.84 Billion | 5.28 Billion | 5.64 Billion | 5.06 Billion | -3.3 Billion | 3.82 Billion |
| Other non-cash items | -3.2 Billion | 158.43 Million | 102.14 Million | 204.47 Million | -9.4 Million | 64.03 Million |
| Investing Cash Flow | -15.85 Billion | -4.24 Billion | -1.82 Billion | -10.51 Billion | -446.08 Million | -3.17 Billion |
| Investments in PPE | -438.54 Million | -914.69 Million | -1.16 Billion | -9.11 Billion | -1.27 Billion | -2.8 Billion |
| Acquisitions | - | - | -688.9 Million | -2.31 Billion | - | -354.73 Million |
| Investment purchases | - | -4.24 Billion | -3.1 Million | -503.1 Million | - | - |
| Sales/Maturities of investments | - | 513.36 Million | -5.89 Million | 1.05 Billion | 1.05 Billion | 3 Million |
| Other Investing Activities | -15.42 Billion | 367.49 Million | 797.54 Million | 255.08 Million | 266.49 Million | -26.6 Million |
| Financing Cash Flow | -46.44 Million | 27.47 Billion | 9.89 Billion | 7.73 Billion | -425.28 Million | -4.43 Billion |
| Debt repayment | -106.44 Million | -27.58 Billion | -9.99 Billion | -8.33 Billion | -271.25 Million | -2.97 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -1.27 Billion |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 60 Million | -15 Million | 9.89 Billion | 8.33 Billion | -425.28 Million | -3.15 Billion |
| Accounts receivables | 1.72 Billion | -555.32 Million | 255.58 Million | -993.87 Million | -693.57 Million | 2.23 Billion |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -638.03 Million | -926.68 Million | 2.11 Billion | 3.9 Billion | -1.94 Billion | 1.75 Billion |
| Other working capital | -3.93 Billion | 5.47 Billion | 3.92 Billion | 1.69 Billion | -1.22 Billion | 1.17 Million |
| Cash at beginning of period | 29.08 Billion | 16.51 Billion | 8.8 Billion | 15.79 Billion | 16.47 Billion | 10.47 Billion |
| Cash at end of period | 10.3 Billion | 29.08 Billion | 16.51 Billion | 16.51 Billion | 8.8 Billion | 16.47 Billion |
| Capital Expenditure | -438.54 Million | -914.69 Million | -1.16 Billion | -9.11 Billion | -1.27 Billion | -2.8 Billion |
| Effect of forex changes on cash | -94.77 Million | 111.89 Million | -151.45 Million | -70.18 Million | 116.05 Million | -175.66 Million |
| Net cash flow / Change in cash | -18.77 Billion | 12.56 Billion | 7.71 Billion | 720.01 Million | -7.66 Billion | 5.99 Billion |
| Free Cash Flow | -3.21 Billion | -11.69 Billion | -1.36 Billion | -5.55 Billion | -8.18 Billion | 10.97 Billion |
AFBI
4996
PSD
RHT
PECOS
473370